Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002539028 | SCV001010567 | likely benign | Hypertrophic cardiomyopathy 11; Dilated cardiomyopathy 1R; Atrial septal defect 5 | 2023-06-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001179606 | SCV001344311 | likely benign | Cardiomyopathy | 2019-06-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003307622 | SCV003996034 | likely benign | Cardiovascular phenotype | 2023-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV004003037 | SCV004844838 | likely benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000869162 | SCV001928644 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000869162 | SCV001951847 | likely benign | not provided | no assertion criteria provided | clinical testing |